Stock Price
11.53
Daily Change
-0.08 -0.65%
Monthly
14.38%
Yearly
11.78%
Q4 Forecast
11.32

EPS Reference Time Actual Consensus Previous
2026-11-02 FY2026Q3 0.30 0.26 0.18
2026-07-28 FY2026Q2 0.22 0.23 0.19
2026-05-07 FY2026Q1 0.15 0.15 0.12
2026-02-26 FY2025Q4 0.25 0.25 0.23
2025-11-04 FY2025Q3 0.18 0.2 0.16



Peers Price Chg Day Year Date
Alcon AG 61.80 -0.34 -0.55% 3.10% Nov/17
Almirall 10.50 -0.14 -1.32% -14.63% Nov/17
Amarin 11.27 -0.04 -0.35% -29.74% Nov/17
Amadeus IT 61.92 -1.52 -2.40% -0.64% Nov/17
argenx SE 854.40 -23.20 -2.64% 8.34% Nov/17
AstraZeneca 13,802.00 -232.00 -1.65% 1.74% Nov/17
Bayer 56.14 -0.86 -1.51% 105.12% Nov/17
Cie Automotive 26.10 -0.25 -0.95% -8.42% Nov/17
Essilor 179.20 -5.30 -2.87% -42.45% Nov/17
Ence Energia y Celulosa 2.24 0.01 0.27% -3.79% Nov/17

Indexes Price Day Year Date
ES35 19586 -321.30 -1.61% 23.75% Nov/17
EU600 651 -11.59 -1.75% 15.82% Nov/17

GRIFOLS traded at 11.53 this Tuesday November 17th, decreasing 0.08 or 0.69 percent since the previous trading session. Looking back, over the last four weeks, GRIFOLS lost 14.34 percent. Over the last 12 months, its price rose by 11.73 percent. Looking ahead, we forecast GRIFOLS to be priced at 11.32 by the end of this quarter and at 10.39 in one year, according to Trading Economics global macro models projections and analysts expectations.

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.